Literature DB >> 18340078

Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation.

Gregory Y H Lip1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18340078      PMCID： PMC2267987          DOI： 10.1136/bmj.39351.706586.AD

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  15 in total

1.  Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS).

Authors:  P Lechat; H Lardoux; A Mallet; P Sanchez; G Derumeaux; T Lecompte; L Maillard; J L Mas; F Mentre; F Pousset; L Lacomblez; G Pisica; S Solbes-Latourette; P Raynaud; P Chaumet-Riffaud
Journal:  Cerebrovasc Dis       Date:  2001       Impact factor: 2.762

Review 2.  Anticoagulation plus aspirin following acute myocardial infarction: yes or no ... and if the latter, why not?

Authors:  Gregory Y H Lip; Chetan Varma
Journal:  Thromb Res       Date:  2005-11-07       Impact factor: 3.944

3.  Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.

Authors:  Zakaria Khurram; Eric Chou; Robert Minutello; Geoffrey Bergman; Manish Parikh; Srihari Naidu; S Chiu Wong; Mun K Hong
Journal:  J Invasive Cardiol       Date:  2006-04       Impact factor: 2.022

4.  Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

Authors:  Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

Review 5.  Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials.

Authors:  Francesco Dentali; James D Douketis; Wendy Lim; Mark Crowther
Journal:  Arch Intern Med       Date:  2007-01-22

6.  Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.

Authors:  S Connolly; J Pogue; R Hart; M Pfeffer; S Hohnloser; S Chrolavicius; M Pfeffer; S Hohnloser; S Yusuf
Journal:  Lancet       Date:  2006-06-10       Impact factor: 79.321

7.  Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.

Authors:  Pasi P Karjalainen; Pekka Porela; Antti Ylitalo; Saila Vikman; Kai Nyman; Mari-Anne Vaittinen; Tuukka J Airaksinen; Matti Niemelä; Tero Vahlberg; K E Juhani Airaksinen
Journal:  Eur Heart J       Date:  2007-01-31       Impact factor: 29.983

8.  Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline.

Authors:  Gregory Y H Lip; Manas Karpha
Journal:  Chest       Date:  2006-12       Impact factor: 9.410

9.  Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.

Authors:  Greg C Flaker; Michael Gruber; Stuart J Connolly; Steven Goldman; Sandra Chaparro; Alec Vahanian; Matti O Halinen; Jay Horrow; Jonathan L Halperin
Journal:  Am Heart J       Date:  2006-11       Impact factor: 4.749

10.  Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.

Authors:  James L Orford; Panayotis Fasseas; Steven Melby; Kelli Burger; Steven R Steinhubl; David R Holmes; Peter B Berger
Journal:  Am Heart J       Date:  2004-03       Impact factor: 4.749
View more
  7 in total

1.  [Antithrombotic and anticoagulation therapy after stroke and transient ischemic attacks].

Authors:  R Weber; B Frank; H-C Diener
Journal:  Nervenarzt       Date:  2010-12       Impact factor: 1.214

Review 2.  Stroke prevention in atrial fibrillation: putting the guidelines into practice.

Authors:  Jonathan Mant; Duncan Edwards
Journal:  Drugs Aging       Date:  2010-11-01       Impact factor: 3.923

Review 3.  Stroke prevention: an update.

Authors:  Marie-Germaine Bousser
Journal:  Front Med       Date:  2012-03-31       Impact factor: 4.592

Review 4.  [Anticoagulation in the elderly].

Authors:  J Harenberg; R Bauersachs; C Diehm; H Lawall; H Burkhardt; H Gerlach; H Darius; H Völler; E Rabe; M Wehling
Journal:  Internist (Berl)       Date:  2010-11       Impact factor: 0.743

5.  Risk scores and geriatric profile: can they really help us in anticoagulation decision making among older patients suffering from atrial fibrillation?

Authors:  Frédéric Maes; Olivia Dalleur; Séverine Henrard; Dominique Wouters; Christophe Scavée; Anne Spinewine; Benoit Boland
Journal:  Clin Interv Aging       Date:  2014-07-15       Impact factor: 4.458

Review 6.  Aspirin Compared to Low Intensity Anticoagulation in Patients with Non-Valvular Atrial Fibrillation. A Systematic Review and Meta-Analysis.

Authors:  Fernando J Vazquez; Joaquín P Gonzalez; Esteban Gándara
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240

7.  Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study.

Authors:  Laila Staerk; Gregory Y H Lip; Jonas B Olesen; Emil L Fosbøl; Jannik L Pallisgaard; Anders N Bonde; Anna Gundlund; Tommi B Lindhardt; Morten L Hansen; Christian Torp-Pedersen; Gunnar H Gislason
Journal:  BMJ       Date:  2015-11-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.